Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Net Medical Announces Strategic Partnership with Accorto Regulatory Solutions

ALBUQUERQUE, NM / ACCESSWIRE / June 21, 2022 / Further broadening its FDA Clinical Trials program. Net Medical (OTC PINK:NMXS) announced today a new strategic partnership with Accorto Regulatory Solutions.

Net Medical Xpress Solutions, Inc., Tuesday, June 21, 2022, Press release picture

Dick Govatski, CEO, Net Medical said, "We're expanding our CLIA Moderate Complex Lab to assist regulatory firms with human factor studies and clinical trials for virus tests. The new joint effort with Accorto Regulatory Solutions is specifically designed to help small to mid-sized domestic and international companies bring their FDA regulated products to market.

"FDA Clinical Trials are essential steps in the process for regulatory firms to meet the requirements of either EUA (Emergency Use Authorizations) or 510k clearances for their products. Net Medical assists firms like Accorto to streamline the process of filing with the FDA to meet the strict procedures necessary to comply with federal regulations."

Russ Rogers, Accorto's Chief Strategy Officer, said, "We are pleased to work with Net Medical, which has the technology, expertise and personnel to help facilitate positive results for our clients."

Govatski added, "Eventually, EUA designations for COVID products will end. It will be important for companies to be able to transition from EUA clearances to 510k clearances. With our scientists, well-trained staff and lab personnel, Net Medical offers regulatory firms both clinical and human factor services to enhance their own efforts. Our dual language staff provides both English and Spanish trial results.

About Accorto Accorto Regulatory Solutions, a regulatory consulting firm based out of Richmond, Virginia, specializes in providing a multitude of analytical and regulatory compliance solutions for their clients in the medical, biotechnology, diagnostics, pharmaceutical and nicotine industries. Their firm has perfected its processes to develop bespoke, cost-effective turnkey regulatory application solutions in a rangee of FDA regulated areas.

About Net Medical - publicly traded (OTC Pink:NMXS) since 1999.

Net Medical has two operating units. Net Medical Labs is a moderate complex CLIA certified lab that specializes in virus and infection testing and diagnostics. The company's mobile fleet of vans provide COVID and flu testing in New Mexico for schools, companies, homeless shelters and nursing homes. The company provides a unique Test-To-Treat program for home and office care that combines both diagnostic and pharmaceutical services that are particularly valuable in rural communities. The lab also serves as a reference lab for physician offices and other facilities that lack services for complex virus diagnostics. Net Medical Xpress provides telemedicine solutions for hospitals, nursing homes, specialty hospitals and other medical facilities. The company maintains a 24/7/365 call center, a team of software developers and telemedicine platforms.

For more information, call 505-255-1999 X 320. Visit www.netmedical.com. Email ir@netmedical.com

Forward-Looking Statements. This press releasecontainsforward-looking statements within the meaning ofSection 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are the company's currentexpectations about future events and can be identified by terms such as "plans," "expect," "may," "anticipate," "intend," "should be," "will be," "is likely to," "believes," and similarexpressionsreferring tofuture periods. The company believes any expectations reflected in the forward-looking statements are reasonable but cannot guaranteefuture results, level of activity, performance or achievements. Actual results may differ materially from those expressed or implied in the forward-looking statements.

SOURCE: Net Medical Xpress Solutions, Inc.



View source version on accesswire.com:
https://www.accesswire.com/705838/Net-Medical-Announces-Strategic-Partnership-with-Accorto-Regulatory-Solutions

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.